Payal S. Patel

Pediatrics
15900 W 127th St Ste 261
Lemont, IL 60439

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML).

A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML).

Journal: Leukemia research
Published: March 15, 2016
Showing 1-1 of 1

Last Updated: 09/26/2026